U.S (New York) – Report Ocean has recently published a comprehensive research report titled “Liquid Biopsy Market ” Research Report 2023-2031. This report delves deep into the market and offers valuable insights into (Key Market Trends, Emerging Technologies, Market Drivers and Challenges of the Industry, Regulatory Policies), company profiles of key players, and their strategies. With over 100+ market data tables, pie charts, graphs, and figures, this global market study is now available. The report provides a thorough evaluation of the market, (Encompassing Future Trends, Current Growth Factors, Expert Opinions, Factual Information), and industry-validated market data, with a forecast extending until 2031.
The global liquid biopsy market accounted for $1,204.20 million in 2020, and is estimated to reach at $6,804.90 million by 2028, registering a CAGR of 20.9% from 2021 to 2028. Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. This results in liquid biopsy to be potentially less expensive as compared to surgical biopsies. Currently, there are several liquid biopsies in development for oncology. These technological applications and services are being developed for various purposes from research to screening & early detection, assessing biomarker, and providing insights on prognosis & treatment selection. Moreover, some of these tests focus on specific cancer and others are being developed as screening tool for multiple solid tumor cancers.
Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1805
Liquid biopsy is a simple and precise alternative to surgical biopsies, which allows physicians & surgeons to detect & treat cancer at an early stage and acquire tumor information through blood samples. Liquid biopsy also enables the detection of cancer recurrence at earlier than traditional diagnosis methods. Early diagnosis enabled by liquid biopsy tests help healthcare professionals to improve various cancer treatments.
Rise in incidences and prevalence of various cancer types, advantages of liquid biopsy technology, surge in demand of non-invasive procedures, and favorable government initiatives supplement the market growth. However, lack of awareness about cancer and its risk factors, along with limited access to advanced cancer diagnostics technologies in developing regions are expected to hinder the market growth. Furthermore, advantages of liquid biopsy over traditional invasive diagnostics methods is expected to present lucrative growth opportunities for the market.
The liquid biopsy market is categorized on the basis of product & service, cancer type, circulating biomarker, end user, and region. By product & service, it is divided into kits & reagents, platforms & instruments, and services. By cancer type, it is classified into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and other cancers. By circulating biomarker, it is categorized into circulating tumor cell, extracellular vesicle, circulating tumor DNA [ctDNA], and other biomarkers. By end user, it is classified into hospital & laboratory and government & research centers. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1805
According to data from the U.S. Bureau of Economic Analysis and the U.S. Census Bureau, the goods and services deficit increased by $1.9 billion from $68.7 billion in January 2023 to $70.5 billion in February. The increase in the goods and services deficit in February was due to a $2.7 billion increase in the goods deficit to $93.0 billion and a $0.8 billion increase in the services surplus to $22.4 billion. Compared to the same period in 2022, the goods and services deficit has dropped this year by $35.5 billion, or 20.3%. $49.5 billion or 10.8% more was exported. 2.2% or $14.0 billion more was spent on imports.
KEY BENEFITS FOR STAKEHOLDERS
– The study provides an in-depth analysis of the global liquid biopsy market with current trends and future estimations from 2021 to 2028 to elucidate the imminent investment pockets.
– Comprehensive analysis of factors that drive and restrict the market growth is provided
– Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
– Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Key Market Segments
List of key players profiled in the report
– Bio-Rad Laboratories, Inc
– Biocept Inc.
– Guardant Health Inc.
– Illumina, Inc.
– F. Hoffmann-La Roche Ltd.
– Johnson & Johnson
– Laboratory Corporation of America Holdings
– MDxHealth SA
– QIAGEN N.V
– Thermo Fisher Scientific Inc. ArcherDX, Inc., CellMax Life, Epigenomics AG, GRAIL Inc., Freenome Holdings Inc, and others.
BY PRODUCT & SERVICE
– Kits & Reagents
– Platforms & Instruments
– Services
BY CIRCULATING BIOMARKER
– Circulating Tumor Cells
– Extracellular Vesicles
– Circulating Tumor DNA [ctDNA]
– Other Biomarkers
BY CANCER TYPE
– Lung Cancer
– Breast Cancer
– Colorectal Cancer
– Prostate Cancer
– Liver Cancer
– Other Cancers ?
Request To Download Sample of This Strategic Report:: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1805
BY REGION
o North America
? U.S.
? Canada
? Mexico
o Europe
? UK
? Germany
? France
? Italy
? Spain
? Rest of Europe
o Asia-Pacific
? China
? Japan
? India
? Australia
? South Korea
? Taiwan
? Rest of Asia-Pacific
o LAMEA
– Brazil
– Turkey
– Saudi Arabia
– South Africa
– Rest of LAMEA
Why Choose Report Ocean Reports?
Uncovering business opportunities: Our market research reports are invaluable for analyzing potential markets and identifying new product opportunities. They provide insights into customer needs, preferences, and attitudes, as well as facilitate product and service comparisons.
Gaining a clear understanding of your customers: Market reports offer a comprehensive understanding of customers’ needs and desires, empowering your company’s marketing department to enhance products, reduce costs, and improve promotional strategies based on this valuable information.
Data-driven insights: Our market research encompasses a broad spectrum of activities, including market size determination, demand forecasting, competitor analysis, and price monitoring. All these aspects are quantified and measurable, providing you with tangible data-driven insights that enable informed decision-making.
Key Highlights:
Revenue and Sales Estimation: Our reports present historical revenue and sales volume data, which is further triangulated using top-down and bottom-up approaches to forecast the complete market size. Additionally, the report provides estimates for key regions, along with well-recognized types and end-use industries. Macroeconomic factors and regulatory policies are also considered for industry evolution and predictive analysis.
Five Forces Analysis: To enhance market understanding, we conduct a comprehensive five forces analysis that includes evaluating the bargaining power of buyers and suppliers, the threat of new entrants, the threat of substitutes, and the level of rivalry within the market.
Competition: We study leading players in the industry based on their company profile, product portfolio, capacity, product/service pricing, sales performance, and cost/profit analysis.
Demand & Supply and Effectiveness: Our reports provide insights into distribution channels, production, consumption, and, if applicable, import and export activities.
Request full Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1805
About US Report Ocean:
We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.
Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1888 212 3539 (US – TOLL FREE)
Email: sales@reportocean.com
Visit our news website: https://reportocean.com